Efficacy and safety of supaglutide monotherapy in patients with type 2 diabetes

被引：0
|
作者：
Wang, Q. [1 ]
Zhou, Y. [2 ]
Li, L. [1 ]
Wang, W. [3 ]
Tong, G. [3 ]
Shi, B. [4 ]
Hu, X. [5 ]
Bian, F. [6 ]
Li, Q. [7 ]
Wang, Y. [8 ]
Zhao, N. [9 ]
Ma, J. [10 ]
Li, Y. [2 ]
Zhu, D. [3 ]
机构：
[1] Shanghai Innogen Biomed Engn Co Ltd, Shanghai, Peoples R China
[2] Fudan Univ, Shanghai Med Sch, Huashan Hosp, Dept Endocrinol & Metab, Shanghai, Peoples R China
[3] Nanjing Univ, Dept Endocrinol, Drum Tower Hosp, Med Sch, Nanjing, Peoples R China
[4] Soochow Univ, Dept Endocrinol & Metab, Affiliated Hosp 1, Suzhou, Peoples R China
[5] Shandong Univ, Dept Endocrinol & Metab, Jinan Cent Hosp, Jinan, Peoples R China
[6] Cangzhou Peoples Hosp, Dept Endocrinol, Cangzhou, Peoples R China
[7] Zhengzhou Univ, Dept Endocrinol, Affiliated Hosp 2, Zhengzhou, Peoples R China
[8] Nan Yang First Peoples Hosp, Nanyang, Peoples R China
[9] Fudan Univ, Sch Publ Hlth, Shanghai, Peoples R China
[10] Nanjing First Hosp, Dept Endocrinol, Nanjing, Peoples R China
来源：
DIABETOLOGIA | 2023年 / 66卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
640
引用
收藏
页码：S322 / S323
页数：2
相关论文
共 50 条
  • [31] The Efficacy and Safety of Imeglimin as Add-On Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy
    Fouqueray, Pascale
    Pirags, Valdis
    Inzucchi, Silvio
    Bailey, Clifford J.
    Schernthaner, Guntram
    Diamant, Michaela
    Lebovitz, Harold E.
    DIABETES, 2012, 61 : A257 - A257
  • [32] Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus
    I. Raz
    M. Hanefeld
    L. Xu
    C. Caria
    D. Williams-Herman
    H. Khatami
    Diabetologia, 2006, 49 : 2564 - 2571
  • [33] The Efficacy and Safety of Imeglimin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Sitagliptin Monotherapy
    Fouqueray, Pascale
    Pirags, Valdis
    Diamant, Michaela
    Schernthaner, Guntram
    Lebovitz, Harold E.
    Inzucchi, Silvio E.
    Bailey, Clifford J.
    DIABETES CARE, 2014, 37 (07) : 1924 - 1930
  • [34] The efficacy and safety of ISIS 449884 injection as monotherapy in patients with type 2 diabetes: A randomized phase II study
    Ji, Linong
    Gao, Leili
    Feng, Zhikai
    Chen, Guoliang
    Fu, Jing
    Morgan, Erin
    Bhanot, Sanjay
    Gao, Shan
    Zhang, Hongyan
    Liang, Zicai
    Gan, Li-Ming
    DIABETES OBESITY & METABOLISM, 2024, 26 (11): : 5466 - 5469
  • [35] Safety and efficacy of empagliflozin monotherapy in a 52-week study in Japanese patients with type 2 diabetes mellitus
    Woerle, H. J.
    Kadowaki, T.
    Haneda, M.
    Inagaki, N.
    Taniguchi, A.
    Sakamoto, M.
    Koiwai, K.
    Rattunde, H.
    Broedl, U. C.
    DIABETOLOGIA, 2013, 56 : S371 - S372
  • [36] The Efficacy and Safety of Imeglimin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy
    Fouqueray, Pascale
    Pirags, Valdis
    Inzucchi, Silvio E.
    Bailey, Clifford J.
    Schernthaner, Guntram
    Diamant, Michaela
    Lebovitz, Harold E.
    DIABETES CARE, 2013, 36 (03) : 565 - 568
  • [37] The efficacy and safety of pioglitazone (Actos (TM)) As monotherapy and in combination with glibenclamide or metformin in patients with type 2 diabetes mellitus
    Shestakova, M. V.
    Balabolkin, M. I.
    Antsiferov, M. B.
    Mayorov, A. Y.
    Chugunova, L. A.
    Shamkhalova, M. S.
    Brevnova, N. N.
    Naumenkova, I. V.
    Zaytseva, N. V.
    Tsibina, L. V.
    Dedov, I. I.
    DIABETES MELLITUS, 2005, 8 (01): : 50 - 57
  • [38] Efficacy and Safety of Adding Sitagliptin in Patients with Type 2 Diabetes Mellitus with Inadequate Glycaemic Control in Metformin Monotherapy
    Albai, Oana
    Timar, Bogdan
    Timar, Romulus
    PROCEEDINGS OF 6TH INTERNATIONAL CONFERENCE ON INTERDISCIPLINARY MANAGEMENT OF DIABETES MELLITUS AND ITS COMPLICATIONS (INTERDIAB), 2020, : 26 - 33
  • [39] Safety and Efficacy of Empagliflozin Monotherapy in a 52-Week Study in Japanese Patients with Type 2 Diabetes Mellitus
    Kadowaki, Takashi
    Haneda, Masakazu
    Inagaki, Nobuya
    Taniguchi, Atsushi
    Koiwai, Kazuki
    Rattunde, Henning
    Broedl, Uli C.
    Woerle, Hans-Juergen
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [40] Safety, PK, PD, and Efficacy of Weekly Dosing Supaglutide in Patients with T2D
    Zhou, Yue
    Jiang, Xin
    Lou, Yan-Ru
    Ma, Anran
    Li, Jia
    Zhao, Ying
    Prud'homme, Gerald J.
    Wang, Qinghua
    DIABETES, 2022, 71
12345